HALO logo
halo search icon
Climb Bio, Inc.
Climb Bio, Inc.
CLYM · NAS

Climb Bio, Inc.

US$10.91

Price Arrow0.39 (3.71%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Price Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Climb Bio, Inc. Overview

CLYM Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Strong

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Neutral

About CLYM

icon

Website

Climb Bio, Inc.

icon

Telephone

1.866.857.2596

icon

Address

Suite 145, 20 William Street, Wellesley Hills, MA 02481-4103

Description

Climb Bio, Inc. operates as a clinical-stage biotechnology company. It develops therapeutics for patients with immune-mediated diseases. Its lead product candidate, budoprutug, is an anti-CD19 antibody designed for a broad range of B-cell mediated diseases. The company was founded by Andrew D. Levin and Valerie Morisset on October 18, 2018 and is headquartered in Wellesley Hills, MA.

CLYM Price Chart

Key Stats

Market Cap

US$602.38M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.16 - 12.48

Trade Value (12mth)

US$821,563.00

1 week

-2.59%

1 month

13.12%

YTD

180.53%

1 year

776.67%

All time high

29.69

Key Fundamentals

EPS 3 yr Growth

-48.70%

EBITDA Margin

0.00%

Operating Cashflow

-$54m

Free Cash Flow Return

-29.10%

ROIC

-32.10%

Interest Coverage

0.00

Quick Ratio

15.20

Other Data

Shares Outstanding (Fully Diluted)

68m

HALO Sector

Healthcare

Next Company Report Date

08-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CLYM Announcements

Latest Announcements

DateAnnouncements
07 May 26
07 May 26
07 May 26
05 May 26
05 May 26

CLYM Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-1.3-1.53-0.88locklocklock
EPS (Fully Diluted)
$locklocklocklock-1.3-1.53-0.88locklocklock
Growth
%locklocklocklock24.3-17.942.5locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Climb Bio, Inc. (CLYM:NAS)?
Halo FAQ
The current share price of Climb Bio, Inc. (CLYM:NAS) is USD$10.91.
What is the 52-week high share price for Climb Bio, Inc. (CLYM:NAS)?
Halo FAQ
The 52-week high share price for Climb Bio, Inc. (CLYM:NAS) is USD$12.48.
What is the 52-week low share price for Climb Bio, Inc. (CLYM:NAS)?
Halo FAQ
The 52-week low share price for Climb Bio, Inc. (CLYM:NAS) is USD$1.16.
What is the dividend yield for Climb Bio, Inc. (CLYM:NAS)?
Halo FAQ
Climb Bio, Inc. (CLYM:NAS) does not pay a dividend.
What was Climb Bio, Inc. (CLYM:NAS) last dividend payment?
Halo FAQ
Climb Bio, Inc. (CLYM:NAS) does not pay a dividend.
What is the franking level for Climb Bio, Inc. (CLYM:NAS)?
Halo FAQ
Climb Bio, Inc. (CLYM:NAS) has a franking level of 0.00%.
In which sector is Climb Bio, Inc. (CLYM:NAS) classified?
Halo FAQ
Climb Bio, Inc. (CLYM:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.